1. Home
  2. UAA vs SRPT Comparison

UAA vs SRPT Comparison

Compare UAA & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Under Armour Inc.

UAA

Under Armour Inc.

HOLD

Current Price

$5.77

Market Cap

2.4B

ML Signal

HOLD

Logo Sarepta Therapeutics Inc. (DE)

SRPT

Sarepta Therapeutics Inc. (DE)

HOLD

Current Price

$21.07

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UAA
SRPT
Founded
1996
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.4B
IPO Year
N/A
1997

Fundamental Metrics

Financial Performance
Metric
UAA
SRPT
Price
$5.77
$21.07
Analyst Decision
Hold
Hold
Analyst Count
16
28
Target Price
$6.18
$25.68
AVG Volume (30 Days)
15.3M
2.9M
Earning Date
02-06-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,049,070,000.00
$2,413,715,000.00
Revenue This Year
N/A
$13.99
Revenue Next Year
$1.46
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
47.15
52 Week Low
$4.13
$10.42
52 Week High
$8.72
$120.05

Technical Indicators

Market Signals
Indicator
UAA
SRPT
Relative Strength Index (RSI) 68.93 47.33
Support Level $5.39 $20.94
Resistance Level $5.81 $23.00
Average True Range (ATR) 0.29 1.28
MACD 0.04 -0.15
Stochastic Oscillator 79.59 23.53

Price Performance

Historical Comparison
UAA
SRPT

About UAA Under Armour Inc.

Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America, Asia-Pacific, Europe, and Latin America. Consumers of its performance-based clothing and shoes include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through wholesale partners, company-owned digital channels, and approximately 450 company-owned outlet and full-price stores. The Baltimore-based firm was founded in 1996 and is led by controlling shareholder Kevin Plank.

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

Share on Social Networks: